Arcoma AB (ST:ARCOMA) — Market Cap & Net Worth
Market Cap & Net Worth: Arcoma AB (ARCOMA)
Arcoma AB (ST:ARCOMA) has a market capitalization of $13.61 Million (Skr126.49 Million) as of June 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #26270 globally and #558 in its home market, demonstrating a -3.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arcoma AB's stock price Skr8.84 by its total outstanding shares 14308510 (14.31 Million). Review ARCOMA liabilities breakdown to assess the company's total debt and financial obligations.
Arcoma AB Market Cap History: 2015 to 2026
Arcoma AB's market capitalization history from 2015 to 2026. Data shows growth from $12.16 Million to $13.61 Million (2.28% CAGR).
Index Memberships
Arcoma AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.84 Billion | 0.09% | #143 of 281 |
Weight: Arcoma AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Arcoma AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arcoma AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Arcoma AB's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.48x
Arcoma AB's market cap is 1.48 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.16 Million | $123.28 Million | -$6.45 Million | 0.10x | N/A |
| 2016 | $5.81 Million | $102.08 Million | -$11.65 Million | 0.06x | N/A |
| 2017 | $11.55 Million | $91.85 Million | -$9.82 Million | 0.13x | N/A |
| 2018 | $21.02 Million | $119.47 Million | -$1.59 Million | 0.18x | N/A |
| 2019 | $30.49 Million | $133.67 Million | $6.61 Million | 0.23x | 4.61x |
| 2020 | $33.88 Million | $117.42 Million | $1.36 Million | 0.29x | 24.82x |
| 2021 | $20.02 Million | $117.13 Million | -$7.47 Million | 0.17x | N/A |
| 2022 | $11.83 Million | $125.05 Million | $1.90 Million | 0.09x | 6.22x |
| 2023 | $12.24 Million | $163.01 Million | $2.56 Million | 0.08x | 4.77x |
| 2024 | $16.55 Million | $156.81 Million | $11.18 Million | 0.11x | 1.48x |
Competitor Companies of ARCOMA by Market Capitalization
Companies near Arcoma AB in the global market cap rankings as of June 19, 2026.
Key companies related to Arcoma AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Arcoma AB Historical Marketcap From 2015 to 2026
Between 2015 and today, Arcoma AB's market cap moved from $12.16 Million to $ 13.61 Million, with a yearly change of 2.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr13.61 Million | +20.44% |
| 2025 | Skr11.30 Million | -31.72% |
| 2024 | Skr16.55 Million | +35.22% |
| 2023 | Skr12.24 Million | +3.52% |
| 2022 | Skr11.83 Million | -40.92% |
| 2021 | Skr20.02 Million | -40.91% |
| 2020 | Skr33.88 Million | +11.11% |
| 2019 | Skr30.49 Million | +45.05% |
| 2018 | Skr21.02 Million | +82.00% |
| 2017 | Skr11.55 Million | +98.94% |
| 2016 | Skr5.81 Million | -52.28% |
| 2015 | Skr12.16 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Arcoma AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.61 Million USD |
| MoneyControl | $13.61 Million USD |
| MarketWatch | $13.61 Million USD |
| marketcap.company | $13.61 Million USD |
| Reuters | $13.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more